Details for New Drug Application (NDA): 018342
✉ Email this page to a colleague
NDA 018342 describes WELLCOVORIN, which is a drug marketed by Glaxosmithkline and is included in five NDAs. Additional details are available on the WELLCOVORIN profile page.
The generic ingredient in WELLCOVORIN is leucovorin calcium. There are nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the leucovorin calcium profile page.
The generic ingredient in WELLCOVORIN is leucovorin calcium. There are nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the leucovorin calcium profile page.
Summary for 018342
| Tradename: | WELLCOVORIN |
| Applicant: | Glaxosmithkline |
| Ingredient: | leucovorin calcium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018342
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Jul 8, 1983 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Jul 8, 1983 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
